Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nanomagnets Used To Enhance MRI

By Biotechdaily staff writers
Posted on 20 Feb 2007
Nanoscale magnets comprised of iron-containing molecules may soon be used to improve the contrast between healthy and diseased tissue in magnetic resonance imaging (MRI)--as long as the concentration of nanomagnets is precisely controlled.

Molecular nanomagnets are a new class of MRI contrast agents that may offer significant advantages, such as versatility in design, over the compounds currently used. More...
Contrast agents are utilized to highlight different tissues in the body or to help distinguish between healthy and diseased tissue.

Researchers from the U.S. National Institute of Standards and Technology (NIST; Gaithersburg, MD, USA) and their collaborators are currently working with two universities and a hospital to design, produce, and evaluate nanomolecules that might make MR imaging more powerful and easier to perform. The new study resolves a debate in the literature by showing that iron-containing magnets only 2 nm-wide, dissolved in water, can indeed provide accurate contrast in non-clinical MRI images--as long as the nanomagnet concentration is below a specific threshold. Earlier studies by other researchers had reached contradictory conclusions on the utility of molecular nanomagnets for MRI, but without accounting for concentration. NIST scientists, making unique magnetic measurements, were able to monitor the molecules' decomposition and magnetic properties as the composition was varied.

The injectable dyes currently used as MRI contrast agents are of two types. Magnetic ions, which change the nuclear characteristics of hydrogen in water, provide the advantage of consistent identical design but provide low contrast. The second category encompasses particles of thousands of atoms or crystals, which alter local magnetic fields; they provide contrast variation in a larger region but have irregular designs and magnetic properties that are hard to control. By comparison, molecular nanomagnets can be devised to have consistent properties and high contrast. Furthermore, they might be modified to act as "smart” materials whose contrast could be turned on only when bonded to a target molecule or cell. Toxicity should not be a problem, according to the researchers, because iron is naturally found in the body and other studies have found that these materials are non-toxic at the concentrations used in MRI.

NIST researchers are working with Florida State University (Tallahassee, USA) to make single-molecule magnets less than 5 nm in diameter, and are also collaborating with investigators from the University of Colorado (Boulder, USA) to produce nanocrystals in the 10-50 nm range.
The study will be reported in an upcoming issue of the journal Polyhedron.





Related Links:
National Institute of Standards and Technology

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: Pathlight combines WGS and dPCR to identify and longitudinally track large‑scale genomic changes, known as structural variants (photo courtesy of SAGA Diagnositcs)

Roche Affiliate Expands MRD Portfolio with SAGA Acquisition

Foundation Medicine, Inc., an independent affiliate of Roche, announced plans to expand its monitoring portfolio with SAGA Diagnostics’ Pathlight, a personalized, tumor-informed molecular residual disease... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.